News

Share your News

MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.

Submit News

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates BioConnections® Jobs Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News

MichBio seeks a highly motivated individual who can work creatively in a small team environment and assist in data mining, compilation, and...

Read Post

Principal Scientist - BiophysicsKalamazoo, MI • Full-Time Proteos, Inc. is a wholly owned subsidiary of NanoImaging Services, Inc. (NIS)...

Read Post

Congress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...

Read Post

The White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...

Read Post

The Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...

Read Post

MichBio’s 2025 Michigan BioIndustry Workforce Trends Report highlights a biosciences sector that is both resilient and evolving, with strong...

Read Post

As the medical device industry continues to evolve, manufacturers increasingly rely on partners who can combine precision engineering,...

Read Post

The future of the SBIR/STTR programs has been a critical issue for the life sciences innovation ecosystem, as highlighted in prior biolink...

Read Post

The U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...

Read Post

A new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...

Read Post

The FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...

Read Post

A bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...

Read Post